Abdulameer SA. Knowledge and pharmaceutical care practice regarding inhaled therapy among registered and unregistered pharmacists: an urgent need for a patient-oriented health care educational program in Iraq. Int J Chron Obstruct Pulmon Dis, 2018; 13:879–88. https://doi.org/10.2147/COPD.S157403 | | Abdullah L, Margolis S, Townsend T. Primary health care patients' knowledge about diabetes in the United Arab Emirates. East Mediterr Health J, 2001; 7:662–70. | | | American Diabetes Association. Standards of medical care in diabetes—2014. Diabetes Care, 2014; 37:S14–80. https://doi.org/10.2337/dc14-S014 | | | Babelgaith SD. Assessment of the knowledge and practice of health care professionals towards diabetes care in Mukalla, Yemen. IJPTP, 2013; 4:826–31. | | | Bisheya AF, El-Mijbri SA, Beshyah SA, Sherif IH. Community pharmacists' knowledge, attitudes and practices in diabetes care in tripoli, Libya. Ibnosina J Med Biomed Sci, 2011; 3:89–95. https://doi.org/10.4103/1947-489X.210877 | | | Blenkinsopp A, Hassey A. Effectiveness and acceptability of community pharmacy-based interventions in type 2 diabetes: a critical review of intervention design, pharmacist and patient perspectives. Int J Pharm Pract, 2005; 13:231–40. https://doi.org/10.1211/ijpp.13.4.0001 | | | Borges APDS, Guidoni CM, Freitas OD, Pereira LRL. Economic evaluation of outpatients with type 2 diabetes mellitus assisted by a pharmaceutical care service. Arq Bras Endocrinol Metabol, 2011; 55:686–91. https://doi.org/10.1590/S0004-27302011000900003 | | | Borges APDS, Guidoni CM, Ferreira LD, Freitas OD, Pereira LRL. The Pharmaceutical care of patients with type 2 diabetes mellitus. Pharm World Sci, 2010; 32:730–6. https://doi.org/10.1007/s11096-010-9428-3 | | | Brennan TA, Dollear TJ, Hu M, Matlin OS, Shrank WH, Choudhry NK, Grambley W. An integrated pharmacy-based program improved medication prescription and adherence rates in diabetes patients. Health Aff (Millwood), 2012; 31:120–9. https://doi.org/10.1377/hlthaff.2011.0931 | | | Chen H-Y, Lee T-Y, Huang W-T, Chang C-J, Chen C-M. The short-term impact of a continuing education program on pharmacists' knowledge and attitudes toward diabetes. Am J Pharm Educ, 2004; 68:121. https://doi.org/10.5688/aj6805121 | | | Chow EP, Hassali MA, Saleem F, Aljadhey H. Effects of pharmacist-led patient education on diabetes-related knowledge and medication adherence: a home-based study. Health Educ J, 2016; 75:421–33. https://doi.org/10.1177/0017896915597021 | | | Cochran WG. Sampling techniques. John Wiley & Sons, New York, NY, 1977. | | | El Hajj MS, Abu Yousef SE, Basri MA. Diabetes care in Qatar: a survey of pharmacists' activities, attitudes and knowledge. Int J Clin Pharm, 2018; 40:84–93. https://doi.org/10.1007/s11096-017-0562-z | | | Erku DA, Belachew SA, Mekuria AB, Haile KT, Melaku B, Tegegn HG, Ayele AA. The role of community pharmacists in patient counseling and health education: a survey of their knowledge and level of involvement in relation to type 2 diabetes mellitus. Integr Pharm Res Pract, 2017; 6:137–43. https://doi.org/10.2147/IPRP.S140777 | | | Guariguata L, Whiting D, Hambleton I, Beagley J, Linnenkamp U, Shaw J. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract, 2014; 103:137–49. https://doi.org/10.1016/j.diabres.2013.11.002 | | | Hermansen-Kobulnicky CJ, Worley MM. Exploring the patient perspective regarding community pharmacists' educational roles in diabetes medication and blood glucose management. Int J Pharm Pract, 2008; 16:81–90. https://doi.org/10.1211/ijpp.16.2.0005 | | | Ibrahim IR, Al Tukmagi HF, Wayyes A. Attitudes of Iraqi society towards the role of community pharmacists. Inov Pharm, 2013; 4:1–10. https://doi.org/10.24926/iip.v4i2.296 | | | International Diabetes Federation. The IDF Middle East and North Africa (MENA) Region. 2017. Available via https://www.idf.org/our-network/regions-members/middle-east-and-north-africa/members/36-iraq. html (Accessed 20 December 2017). | | | Irons BK, Lenz RJ, Anderson SL, Wharton BL, Habeger B, Anderson HG. A retrospective cohort analysis of the clinical effectiveness of a physician-pharmacist collaborative dsrug therapy management diabetes clinic. Pharmacotherapy, 2002; 22:1294–300. https://doi.org/10.1592/phco.22.15.1294.33476 | | | Karter AJ, Parker MM, Duru OK, Schillinger D, Adler NE, Moffet HH, Adams AS, Chan J, Herman WH, Schmittdiel JA. Impact of a pharmacy benefit change on new use of mail order pharmacy among diabetes patients: the Diabetes Study of Northern California (DISTANCE). Health Serv Res, 2015; 50:537–59. https://doi.org/10.1111/1475-6773.12223 | | | Kraemer DF, Kradjan WA, Bianco TM, Low JA. A randomized study to assess the impact of pharmacist counseling of employer-based health plan beneficiaries with diabetes: the EMPOWER study. J Pharm Pract, 2012; 25:169–79. https://doi.org/10.1177/0897190011418513 | | | Leal S, Glover JJ, Herrier RN, Felix A. Improving quality of care in diabetes through a comprehensive pharmacist-based disease management program. Diabetes Care, 2004; 27:2983–4. https://doi.org/10.2337/diacare.27.12.2983 | | | Mansour AA, Al-Maliky AA, Kasem B, Jabar A, Mosbeh KA. Prevalence of diagnosed and undiagnosed diabetes mellitus in adults aged 19 years and older in Basrah, Iraq. Diabetes Metab Syndr Obes, 2014; 7:139–44. https://doi.org/10.2147/DMSO.S59652 | | | Odili V, Oparah A. Immediate impact of a diabetes mellitus education programme on the knowledge of pharmacists. West Afr J Pharm, 2013; 24:58–63. | | | Perez A, Doloresco F, Hoffman JM, Meek PD, Touchette DR, Vermeulen LC, Schumock GT. Economic evaluations of clinical pharmacy services: 2001–2005. Pharmacotherapy, 2009; 29:128. https://doi.org/10.1592/phco.29.1.128 | | | Pinto SL, Lively BT, Siganga W, Holiday-Goodman M, Kamm G. Using the Health Belief Model to test factors affecting patient retention in diabetes-related pharmaceutical care services. Res Social Adm Pharm, 2006; 2:38–58. https://doi.org/10.1016/j.sapharm.2005.11.001 | | | Shareef J, Nandakumar U, Bhat M. A study on assessment of adverse drug reactions in patients with Tuberculosis in a tertiary care teaching hospital. J Appl Pharm Sci, 2018; 8:99–104. | | | Shatnawi A, Latif DA. A qualitative assessment of West Virginia pharmacist activities and attitude in diabetes management. J Eval Clin Pract, 2016; 23:586–92. https://doi.org/10.1111/jep.12677 | | | Shrestha M, Maharjan R, Prajapati A, Ghimire S, Shrestha N, Banstola A. Assessment of knowledge and practice of community pharmacy personnel on diabetes mellitus management in Kathmandu district: a cross sectional descriptive study. J Diabetes Metab Disord, 2015; 14:71. https://doi.org/10.1186/s40200-015-0205-7 | | | Simpson SH, Haggarty S, Johnson JA, Schindel TJ, Tsuyuki RT, Lewanczuk R. Survey of pharmacist activities and attitudes in diabetes management. Can Pharm J (Ott), 2009; 142:128–34. https://doi.org/10.3821/1913-701X-142.3.128 | | | Smith M. Pharmacists' role in improving diabetes medication management. J Diabetes Sci Technol, 2009; 3:175–9. https://doi.org/10.1177/193229680900300120 | | | Struijs JN, Baan CA, Schellevis FG, Westert GP, Van Den Bos GA. Comorbidity in patients with diabetes mellitus: impact on medical health care utilization. BMC Health Serv Res, 2006; 6:84. https://doi.org/10.1186/1472-6963-6-84 | | | Touchette DR, Doloresco F, Suda KJ, Perez A, Turner S, Jalundhwala Y, Tangonan MC, Hoffman JM. Economic evaluations of clinical pharmacy services: 2006–2010. Pharmacotherapy, 2014; 34:771–93. https://doi.org/10.1002/phar.1414 | | | Turnacilar M, Sancar M, Apikoglu-Rabus S, Hursitoglu M, Izzettin FV. Improvement of diabetes indices of care by a short pharmaceutical care program. Pharm World Sci, 2009; 31:689–95. https://doi.org/10.1007/s11096-009-9333-9 | | | Wertz D, Hou L, Devries A, Dupclay Jr L, Mcgowan F, Malinowski B, Cziraky M. Clinical and economic outcomes of the Cincinnati Pharmacy Coaching Program for diabetes and hypertension. Manag Care, 2012; 21:44–54. | | |
|
